In vitro fertilization costs to be covered by NHIF at 11 clinics, list also includes 61 new drugs
Source: Blic
Tuesday, 15.01.2019.
09:29
Comments
(Photo: EM Karuna/shutterstock.com)
The list will feature therapy alternatives for drugs for cardiovascular diseases, diabetes and rheumatology diseases.
– The list also features innovative drugs for psoriasis and BRAF-positive metastatic melanoma – Radojevic Skodric said on RTS, as reported by Blic.
She notes that she expects the government to adopt the new list and adds:
– This year, the state plans to sign agreements with 11 private clinics where in vitro fertilization can be carried out. The public call for clinics is open until January 31.
According to Radojevic Skodric, 1,700 in vitro fertilization procedures were carried out at the expense of the NHIF in 2015, whereas, in 2018, the number was around 3,800. She also pointed out that, in 2018, six embryos were frozen at the expense of the state for the first time, for a five-year period.
– Another important thing is that those who had their first child through in vitro fertilization may apply for the second procedure – the director of the NHIF says.
She also says that new regulations for medical treatment abroad will be adopted this year.
– The regulations will feature indications and diseases that could not have been treated abroad. Certain genetic analyses will also be available outside of Serbia.
Radojevic Skodric says that the call center through which citizens can learn about their health insurance rights opened in late November.
It is available at +381 0700 333 443 (at the price of a local call) and +381 11 735 0900 for mobile calls and calls from abroad.
Tags:
National Health Insurance Fund
NHIF
Sanja Radojevic Skodric
medical drugs on NHIF list
new drugs on NHIF list
drugs for cardiovascular diseases
drugs for diabetes
drugs for rheumatology diseases
drugs for psoriasis
drugs for metastatic melanoma
in vitro fertilization
health insurance call center
Comments
Your comment
Most Important News
Full information is available only to commercial users-subscribers and it is necessary to log in.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno,
uz konsultacije sa našim ekspertima.